Duke Urology Database and Specimen Bank

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Judd Moul, Duke University
ClinicalTrials.gov Identifier:
NCT00978991
First received: September 15, 2009
Last updated: February 6, 2013
Last verified: February 2013
  Purpose

The proposed project is aimed to build a Duke University-specific longitudinal urologic surgery database. It will be used as the main resource to support future research within Urology and Duke University.


Condition
Prostate Cancer
Bladder Cancer
Erectile Dysfunction
Incontinence

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Duke Longitudinal Urologic Surgery Patient Outcome Database

Resource links provided by NLM:


Further study details as provided by Duke University:

Enrollment: 87820
Study Start Date: January 1988
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Specifically, the database will be used for the following future studies. (i) To characterize the biomarkers/protein signature associated with urological diseases; (ii) To clarify the clinical role of the risk factors and their interactions for early detection and optimized treatment of urological diseases, and improvement of post-treatment quality of life; (iii) To develop algorithms and nomograms to accurately predict the outcome of urological diseases.

Retrospective review of subjects data prior to Institutional Review Board approval and prospective review of data on those consented after Institutional Review Board approval.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Urology

Criteria

Inclusion Criteria:

  • Duke Urology patients

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00978991

Locations
United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Investigators
Principal Investigator: Judd W Moul, MD Duke University
  More Information

No publications provided

Responsible Party: Judd Moul, Professor of Surgery, Duke University
ClinicalTrials.gov Identifier: NCT00978991     History of Changes
Other Study ID Numbers: Pro00005140
Study First Received: September 15, 2009
Last Updated: February 6, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Duke University:
Benign prostate hyperplasia
Erectile dysfunction

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Prostatic Neoplasms
Erectile Dysfunction
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases
Genital Neoplasms, Male
Genital Diseases, Male
Prostatic Diseases
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Sexual and Gender Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 21, 2014